Literature DB >> 11774084

Evolution and current use of the tuberculin test.

Elsie Lee1, Robert S Holzman.   

Abstract

Since it was first introduced in the late 1800s, the tuberculin test has undergone continual refinement in its formulation, standardization, and dosage, as well as its interpretation and indications for use. New guidelines have replaced universal screening with targeted testing and rigid definitions of positivity with individualized criteria formulated from a Bayesian approach. This review summarizes the evolution of the test and provides information to help gauge its predictive value.

Mesh:

Substances:

Year:  2001        PMID: 11774084     DOI: 10.1086/338149

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  30 in total

1.  Differences in tuberculin reactivity as determined in a veterans administration employee health screening program.

Authors:  Sanjay R Mehta; Cathy MacGruder; David Looney; Scott Johns; Davey M Smith
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

2.  Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children.

Authors:  T G Connell; N Curtis; S C Ranganathan; J P Buttery
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

3.  Deciphering the proteome of the in vivo diagnostic reagent "purified protein derivative" from Mycobacterium tuberculosis.

Authors:  Yun Sang Cho; Karen M Dobos; Jessica Prenni; Hongliang Yang; Ann Hess; Ida Rosenkrands; Peter Andersen; Sung Weon Ryoo; Gill-Han Bai; Michael J Brennan; Angelo Izzo; Helle Bielefeldt-Ohmann; John T Belisle
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

4.  Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran.

Authors:  Masoud Mardani; Payam Tabarsi; Zohre Mohammadtaheri; Ehsan Chitsaz; Banafsheh Farokhzad; Fatemeh Hadavand; Latif Gachkar; Kambiz Nemati; Mohammad R Masjedi
Journal:  Ann Thorac Med       Date:  2010-01       Impact factor: 2.219

5.  Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals.

Authors:  Seok-Yong Eum; Ye-Jin Lee; Hyun-Kyung Kwak; Jin-Hong Min; Soo-Hee Hwang; Laura E Via; Clifton E Barry; Sang-Nae Cho
Journal:  Diagn Microbiol Infect Dis       Date:  2008-03-04       Impact factor: 2.803

6.  High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.

Authors:  S S J Lee; K J Chou; I J Su; Y S Chen; H C Fang; T S Huang; H C Tsai; S R Wann; H H Lin; Y C Liu
Journal:  Infection       Date:  2008-12-10       Impact factor: 3.553

7.  Successful expression and purification of DPPD using a codon optimized synthetic gene.

Authors:  Suely S Kashino; Antonio Campos-Neto
Journal:  Open J Immunol       Date:  2011-06-30

8.  Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.

Authors:  Kimberly M Shea; J Steve Kammerer; Carla A Winston; Thomas R Navin; C Robert Horsburgh
Journal:  Am J Epidemiol       Date:  2013-10-18       Impact factor: 4.897

9.  Improved diagnostic evaluation of suspected tuberculosis.

Authors:  Davinder P S Dosanjh; Timothy S C Hinks; John A Innes; Jonathan J Deeks; Geoffrey Pasvol; Sarah Hackforth; Hansa Varia; Kerry A Millington; Rubamalar Gunatheesan; Valerie Guyot-Revol; Ajit Lalvani
Journal:  Ann Intern Med       Date:  2008-03-04       Impact factor: 25.391

10.  Predictors of delayed-type hypersensitivity to Candida albicans and anti-Epstein-Barr virus antibody among children in Kilimanjaro, Tanzania.

Authors:  Katherine Wander; Bettina Shell-Duncan; Eleanor Brindle; Kathleen O'Connor
Journal:  Am J Phys Anthropol       Date:  2013-03-04       Impact factor: 2.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.